Manufactured and distributed by Sanofi-Aventis
Contact your PlexusDx care team to explore slower dose escalation, increased hydration protocols, or switching to oral semaglutide ($289/month) or another compound
Suitability is determined following consultation
Boesmans, W., Owsianik, G., Tack, J., Voets, T
View the full release here: By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts Nearly two-thirds of Canadian adults are overweight or living with obesity, but cost has remained a significant barrier to access the treatment they need